Prolepsia forecastNumber
What will Anthropic's (Nasdaq: ANT) closing share price be on March 31, 2027?
As of 20 November 2026, Prolepsia’s median forecast is $89.4 per share, with an 80% chance it falls between $50.9 and $152 per share.
$89.4per share, median
Values in USD per share
How Prolepsia reasons
The report Prolepsia wrote with this forecast.
How forecasts are made · Track record
TL;DR
10th percentile: $50.90 per share Closing price on March 31, 2027; Median (50th percentile): $89.40 per share Closing price on March 31, 2027; 90th percentile: $152.10 per share Closing price on March 31, 2027. The median is below Anthropic’s debut close, but the wide range matters more than the modest downside implied by the median.
Key evidence
Anthropic priced its IPO at $83.00, opened at $111.50, and finished its first regular session at $97.17. An early November 20 premarket quote of $91.65 showed further weakness. An early quote carries less weight than a regular-session close, but both are more useful than the opening trade for judging where the stock stood after its debut.
Comparable IPOs give a stronger case for a wide range than for a particular direction. Some groups of technology listings were roughly flat over a similar period; others fell materially. The broader IPO record also argues against assuming that a successful debut predicts strong aftermarket returns.
The first public earnings report matters for two reasons. It will test whether rapid revenue growth is keeping pace with compute commitments, and the final prospectus ties a major release of restricted shares to those results. Further tranches of up to 275 million Class A shares each can become eligible in the following weeks. That creates some downside risk, but eligibility does not mean holders will sell, and MSCI’s confirmed addition provides an offsetting source of demand.
Uncertainties
The earnings date was not confirmed as of November 20, so the amount of stock that can become eligible by March 31 remains uncertain. Actual selling, earnings guidance, and broader AI-stock sentiment matter more than the maximum number of eligible shares. The forecast is conditional on a valid official unadjusted regular-session close; it does not assign a price to annulment.
Read the full report
TL;DR
10th percentile: $50.90 per share Closing price on March 31, 2027; Median (50th percentile): $89.40 per share Closing price on March 31, 2027; 90th percentile: $152.10 per share Closing price on March 31, 2027. The median is below Anthropic’s debut close, and the central 80% interval spans a wide range. The first public earnings report is the key event because it tests the growth story and starts the clock on more shares becoming eligible for sale.
Context
As of November 20, 2026, Anthropic had just listed its Class A shares on Nasdaq. The company priced 980 million shares at $83.00 on November 18, and trading began the next day under ANT. The forecast covers 132 calendar days from the debut close, or about 88 trading sessions (Nasdaq trading calendar).
The target is the official, unadjusted regular-session close on March 31, 2027. It is not a measure of the return earned by IPO buyers or the change in Anthropic’s total equity value. A split changes the price used for resolution. The forecast is conditional on a valid close and assigns no price to annulment.
Evidence
The historical record says more about the size of the move than its direction. One group of 20 traditional IPOs had a median 88-session log return close to zero. Another group of 25 technology and technology-adjacent debuts had a median log return of −18.8% over the same number of sessions. The groups differ in size, sector mix, and market conditions. They also share some names, so their disagreement is a warning about peer selection, not evidence of two separate market laws (Yahoo Finance historical prices).
The broader record gives a check on both readings. Average six-month aftermarket returns were 4.9% for IPOs and 5.5% for matched stocks. Those are means over a longer window, not a median prediction for Anthropic. They argue against treating a steep decline in a hand-picked cohort as a universal IPO effect. The selected tech groups still show why the range is wide: median annualized volatility was about 70% in one broad group and 79.4% in another. SpaceX is a useful comparison for offering scale, not for the business itself. Its shares went from $160.95 at the June 12 debut close to $147.96 on October 19, down 8.1% over 88 sessions (Ritter IPO statistics; SpaceX historical prices).
Anthropic’s own trading gives a better starting point than the historical median. After the $83.00 offer, the stock opened at $111.50 on November 19 and closed the regular session at $97.17. It traded at $92.60 late that evening and was quoted at $91.65 early on November 20. A 09:49 UTC Tradegate print of €83.01 was roughly $91 at prevailing exchange rates. The after-hours and premarket indications agree on the direction, but neither has the standing of a regular-session close. The debut also coincided with weakness in technology stocks, so the fall from the opening print is not a clean signal about Anthropic alone (E24).
The business gives investors reasons to pay up and reasons to demand proof. Quarterly revenue rose from $11.555 billion in June to $16.956 billion in September, but the September quarter still showed a $567 million operating loss. The reported annualized revenue run rate rose from about $71 billion at September 30 to about $81 billion at October 31. That is not booked annual revenue. The prospectus also lists about $70.7 billion in compute and infrastructure commitments due in the 12 months after September 30. The next report will help investors judge whether revenue is scaling fast enough to support that spending (final prospectus).
Adoption data give a weaker signal than the company’s financials. On Vercel’s gateway, new teams chose Anthropic nearly two to one over OpenAI in October, yet Anthropic’s share of gateway spending had roughly halved since the prior December to 32%. Both observations can be true: more teams can start using a provider without spending more on it. The panel does not measure Anthropic’s total sales, so it is a reason to watch the gap between adoption and spending, not to infer a slowdown in company revenue (Vercel AI Gateway Production Index).
What's non-obvious
The earnings date affects both the value of the business and the supply of stock. The lock-up is not one cliff after March. Scheduled releases run from December 15 through February 2. Up to 1.5 billion Class A shares can become eligible on the second full trading day after FY2026 results. The prospectus then permits up to 275 million more Class A shares per tranche at 13, 27, 41, 55, and 69 days after results. Results by March 18 or March 4 put one or two of those additional tranches, respectively, inside the forecast window. Airbnb, DoorDash, and Rivian reported their first December-year-end results after listing 56–69 days after year-end. That makes at least one extra tranche plausible, but does not establish Anthropic’s date (final prospectus).
This is a modest drag, not a prediction of forced selling. The terms are public, and newly eligible shares do not all come to market. Demand can rise as well: MSCI confirmed that it would add ANT at the November 30 close, effective December 1. Fast entry to other indexes was possible, but it was not confirmed at the forecast date. The right question is how much stock actually comes to market and who is there to buy it, not how many shares the prospectus permits holders to sell (MSCI announcement).
Uncertainties
One regular session is a thin basis for judging how ANT trades. The early quotes help locate the starting price, but they say little about how it will react to a full earnings release or a broad selloff in AI stocks. Several liquid regular-session closes and a reliable options market covering March would give a better read on the range of outcomes. No usable ANT options prices were available at the forecast cutoff.
The most useful new facts would be the earnings date, the results and guidance, and actual selling around the release dates. Strong revenue with better margins could sustain the valuation even as more shares become eligible. Weak guidance could weigh on the stock even if few holders sell. The selected IPO histories show that large moves in either direction are possible; they do not tell us which surprise Anthropic will deliver.
Forecast history
Values in USD per share
| Date | Forecast |
|---|---|
| Median $89.4 per share, 80% range $50.9 to $152 per share |
Sources Prolepsia read
- Anthropic prices initial public offering \ Anthropicwww.anthropic.com
- Trading Calendarwww.nasdaqtrader.com
- Anthropic, PBC (ANT) Stock Price, News, Quote & History - Yahoo Financefinance.yahoo.com
- IPO-Statisticssite.warrington.ufl.edu
- Anthropic, PBC (ANT) Stock Price, Chart & Newsstockanalysis.com
- Anthropic faller 6 prosent i førhandelene24.no
- final prospectuswww.sec.gov
- Decision models take 26% of requests; Anthropic now wins new teams 2:1 - Vercelvercel.com
- US: ANTHROPIC Aapp2.msci.com
- US & Nordic Stock Market Schedule | Nasdaqwww.nasdaq.com
The question
This question asks for the official closing share price, in U.S. dollars, of Anthropic, PBC Class A common stock (Nasdaq: ANT) on Wednesday, March 31, 2027. As of November 20, 2026, Anthropic has just completed its initial public offering (IPO). The company priced its IPO at $83.00 per share on November 18, 2026, and its Class A shares began trading on the Nasdaq Global Select Market under the ticker ANT on November 19, 2026. Anthropic's IPO was among the largest in stock market history, reflecting substantial investor interest in artificial intelligence companies. The stock opened its first trading session at $111.50, significantly above its IPO price. Sources: [Anthropic IPO announcement](https://www.anthropic.com/news/anthropic-prices-initial-public-offering), [Nasdaq listing announcement](https://www.nasdaq.com/newsroom/anthropic-marks-ipo-at-nasdaq). The forecast concerns the stock's official regular-session closing price on March 31, 2027, rather than its intraday high, intraday low, opening price, after-hours price, or average trading price. March 31, 2027, is a Wednesday and is expected to be a regular Nasdaq trading day. The forecast covers approximately four months following Anthropic's public market debut. The initial forecast range is $30 to $250 per share, although outcomes outside this range remain possible given the volatility and uncertainty associated with recently listed technology companies.
How it resolves
The question will resolve to the official unadjusted closing price of Anthropic, PBC Class A common stock (Nasdaq: ANT) on March 31, 2027, expressed in U.S. dollars per share. The primary resolution source will be Nasdaq's official historical trading data for ANT, specifically the regular-session closing price reported for March 31, 2027. The relevant price is the official closing price established at the end of Nasdaq's regular trading session, normally 4:00 p.m. Eastern Time, excluding premarket and after-hours transactions. If Nasdaq's historical data is unavailable, the closing price reported by a reputable financial data provider such as Bloomberg, LSEG/Refinitiv, or Yahoo Finance may be used, provided the figure represents the official unadjusted regular-session closing price. If sources disagree, Nasdaq's official closing price takes precedence. The outcome will be recorded to two decimal places, using the exchange-reported precision where applicable. If ANT undergoes a stock split or reverse stock split before March 31, 2027, the actual unadjusted closing price per share on that date will be used, reflecting the share structure in effect at that time. No adjustment will be made to express the price in terms of the original IPO share structure. If Anthropic changes its ticker symbol but its Class A common stock remains publicly traded, the closing price of the same security under its successor ticker will be used. If the stock transfers to another recognized U.S. securities exchange, the official closing price on that exchange will be used. If March 31, 2027, unexpectedly becomes a non-trading day because of an exchange-wide closure or trading holiday, the closing price from the most recent preceding trading day on which ANT traded will be used. If ANT is subject to a trading halt or suspension on March 31, 2027, the official closing price reported by its primary exchange for that date will be used if available. If the company is acquired, taken private, permanently delisted, or otherwise ceases public trading before March 31, 2027, and no publicly traded successor security representing the same equity interest exists, the question will be annulled rather than assigning an acquisition price, last historical trading price, or zero. If no reliable official closing price can be established under these rules, the question will also be annulled.
Fine print
The forecast refers exclusively to Anthropic's publicly traded Class A common stock, not other share classes, privately negotiated equity transactions, derivatives, options, or securities issued by other companies. The outcome is a nominal U.S. dollar price per share, without adjustments for inflation, dividends, or changes in exchange rates. The specified $30–$250 range is a forecasting interval rather than a restriction on possible outcomes. Prices below $30 or above $250 remain valid outcomes. A stock split, reverse split, or similar corporate action may materially change the quoted per-share price without producing an equivalent change in the company's total equity valuation. For this reason, the question measures the actual trading price of one share on the resolution date, not Anthropic's market capitalization or investment return since its IPO. If a merger or reorganization results in a directly identifiable publicly traded successor security, the successor's closing price will be used only when the security maintains a one-for-one economic continuity with the original Class A share; otherwise, the question will be annulled. Any market data corrections published by Nasdaq within five trading days after March 31, 2027, will be incorporated before final resolution.
More public forecasts
Will Anthropic (Nasdaq: ANT) be added to the Nasdaq-100 index by January 31, 2027?
>99%chance of yes
Prolepsia forecast
Will Anthropic (Nasdaq: ANT) close above its $83 IPO price on December 31, 2026?
63%chance of yes
Prolepsia forecast
Will the Nasdaq-100 index close at least 20% below its previous all-time closing high on any trading day between 1 January and 31 December 2027?
64%chance of yes
Prolepsia forecast
What share of the vulnerabilities CISA adds to its Known Exploited Vulnerabilities catalog from 1 January to 31 March 2027 will have a fix deadline of three days or less?
77%of new KEV entries with a deadline of 3 days or less, median
Prolepsia forecast
What total revenue will Anthropic report for the quarter ending December 31, 2026?
$21.1billion, median
Prolepsia forecast
Will Reform UK have the highest vote share in YouGov's last Westminster voting intention poll published in 2027?
18%chance of yes
Prolepsia forecast